336 related articles for article (PubMed ID: 14719467)
21. Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin lesions following sulfur mustard exposure: a randomized double-blind clinical trial.
Panahi Y; Davoudi SM; Sahebkar A; Beiraghdar F; Dadjo Y; Feizi I; Amirchoopani G; Zamani A
Cutan Ocul Toxicol; 2012 Jun; 31(2):95-103. PubMed ID: 21988705
[TBL] [Abstract][Full Text] [Related]
22. Immunobiological consequences of sulfur mustard contamination.
Hassan ZM; Ebtekar M; Ghanei M; Taghikhani M; Noori Daloii MR; Ghazanfari T
Iran J Allergy Asthma Immunol; 2006 Sep; 5(3):101-8. PubMed ID: 17237560
[TBL] [Abstract][Full Text] [Related]
23. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
[TBL] [Abstract][Full Text] [Related]
24. Doxepin cream vs betamethasone cream for treatment of chronic skin lesions due to sulfur mustard.
Panahi Y; Davoudi SM; Beiraghdar F; Amiri M
Skinmed; 2011; 9(3):152-8. PubMed ID: 21675494
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of analogues of DRDE-07 as prophylactic agents against the lethality and toxicity of sulfur mustard administered through percutaneous route.
Kulkarni AS; Vijayaraghavan R; Anshoo G; Satish HT; Pathak U; Raza SK; Pant SC; Malhotra RC; Prakash AO
J Appl Toxicol; 2006; 26(2):115-25. PubMed ID: 16421877
[TBL] [Abstract][Full Text] [Related]
26. Dermal and ocular exposure systems for the development of models of sulfur mustard-induced injury.
Weber WM; Kracko DA; Lehman MR; Cox CE; Cheng YS; Grotendorst GR; McDonald JD
Toxicol Mech Methods; 2011 Sep; 21(7):547-53. PubMed ID: 21473735
[TBL] [Abstract][Full Text] [Related]
27. Effects of selected arginine analogues on sulphur mustard toxicity in human and hairless guinea pig skin keratinocytes.
Sawyer TW; Risk D
Toxicol Appl Pharmacol; 2000 Feb; 163(1):75-85. PubMed ID: 10662607
[TBL] [Abstract][Full Text] [Related]
28. N-acetyl-L-cysteine protects against inhaled sulfur mustard poisoning in the large swine.
Jugg B; Fairhall S; Smith A; Rutter S; Mann T; Perrott R; Jenner J; Salguero J; Shute J; Sciuto AM
Clin Toxicol (Phila); 2013 May; 51(4):216-24. PubMed ID: 23547745
[TBL] [Abstract][Full Text] [Related]
29. Modulation of sulfur mustard induced cell death in human epidermal keratinocytes using IL-10 and TNF-alpha.
Qabar A; Nelson M; Guzman J; Corun C; Hwang BJ; Steinberg M
J Biochem Mol Toxicol; 2005; 19(4):213-25. PubMed ID: 16173061
[TBL] [Abstract][Full Text] [Related]
30. Comparison late cutaneous complications between exposure to sulfur mustard and nerve agents.
Emadi SN; Aslani J; Poursaleh Z; Izadi M; Soroush M; Kafashi M; Alavinia SA; Bakhshi H; Karimi A; Momtaz-Manesh K; Babaei AA; Esmaili A; Raygan B; Emadi SE; Babamahmoodi F; Emadi SA
Cutan Ocul Toxicol; 2012 Sep; 31(3):214-9. PubMed ID: 22187952
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse (II): effects of some currently used skin decontaminants (RSDL and Fuller's earth) against liquid sulphur mustard and VX exposure.
Taysse L; Dorandeu F; Daulon S; Foquin A; Perrier N; Lallement G; Breton P
Hum Exp Toxicol; 2011 Jun; 30(6):491-8. PubMed ID: 20534641
[TBL] [Abstract][Full Text] [Related]
32. Development of reactive topical skin protectants against sulfur mustard and nerve agents.
Koper O; Lucas E; Klabunde KJ
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S59-70. PubMed ID: 10594903
[TBL] [Abstract][Full Text] [Related]
33. Topical iodine preparation as therapy against sulfur mustard-induced skin lesions.
Wormser U; Sintov A; Brodsky B; Nyska A
Toxicol Appl Pharmacol; 2000 Nov; 169(1):33-9. PubMed ID: 11076694
[TBL] [Abstract][Full Text] [Related]
34. Putative role of proteolysis and inflammatory response in the toxicity of nerve and blister chemical warfare agents: implications for multi-threat medical countermeasures.
Cowan FM; Broomfield CA; Lenz DE; Smith WJ
J Appl Toxicol; 2003; 23(3):177-86. PubMed ID: 12794939
[TBL] [Abstract][Full Text] [Related]
35. Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics.
Ghabili K; Agutter PS; Ghanei M; Ansarin K; Panahi Y; Shoja MM
Crit Rev Toxicol; 2011 May; 41(5):384-403. PubMed ID: 21329486
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis and treatment of skin lesions caused by sulfur mustard.
Poursaleh Z; Ghanei M; Babamahmoodi F; Izadi M; Harandi AA; Emadi SE; Taghavi NO; Sayad-Nouri SS; Emadi SN
Cutan Ocul Toxicol; 2012 Sep; 31(3):241-9. PubMed ID: 22122127
[TBL] [Abstract][Full Text] [Related]
37. Sulfur mustard-induced poikiloderma: a case report.
Emadi SN; Kaffashi M; Poursaleh Z; Akhavan-Moghaddam J; Soroush MR; Emadi SE; Taghavi NO
Cutan Ocul Toxicol; 2011 Jun; 30(2):170-4. PubMed ID: 21142708
[TBL] [Abstract][Full Text] [Related]
38. Toxicity of mustard gas skin lesions.
Petrali JP; Oglesby-Megee S
Microsc Res Tech; 1997 May; 37(3):221-8. PubMed ID: 9144634
[TBL] [Abstract][Full Text] [Related]
39. Comparison of topical iodine and silver sulfadiazine as therapies against sulfur mustard burns in a pig model.
Margulis A; Chaouat M; Ben-Bassat H; Eldad A; Icekson M; Breiterman S; Neuman R
Wound Repair Regen; 2007; 15(6):916-21. PubMed ID: 18028141
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructural characterization of sulfur mustard-induced vesication in isolated perfused porcine skin.
Monteiro-Riviere NA; Inman AO
Microsc Res Tech; 1997 May; 37(3):229-41. PubMed ID: 9144635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
